| The Spotlight for Sunday, September 10, 2023 | | | | | | Spotlight: 1 Gene Editing Stock Set To Skyrocket Cathie Wood has been investing heavily in Verve Therapeutics (VERV), a company developing therapies for cardiovascular diseases. So what's all the fuss about? We took a deeper dive to find out. Read the full story here
| | | | | |
Spotlight Content You May Have Missed | | | | | | 51% Of Buffett's Portfolio Is In 1 Stock Warren Buffett is one of the most successful investors of all time. He has made billions of dollars by following a simple investment philosophy: invest in companies with strong competitive advantages that are trading at fair prices. One of Buffett's favorite companies is... Read the full story here | | | | | |
| | | | | | Market Commentary: Buffett Loaded Up On 1 Stock Every Quarter For 5 Years Warren Buffett may be old but he's fearless when it comes to making massive bets. One such outsized investment is Apple, which now represents close to 50% of his equity portfolio (see below). Imagine having so much conviction in a single company that you allocate half your money to it. Now further consider having a portfolio... Read the full story here
| | | | | |
| Sponsored | | Prepare for a Recession: Discover the Ideal Stock for Profits | | Don't let a recession catch you off guard. Take action now to secure your wealth.In times of economic downturns, certain stocks have shown resilience and the potential for significant profits. We strongly believe that this stock falls into that category. Go HERE to Learn More | | By clicking the link you are subscribing to The Investor Newsletter Daily Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. | | Privacy Policy/Disclosures |
| | | | | | Spotlight: 1 Heart Transplant Stock Up Over 500% TransMedics (NASDAQ:TMDX) has emerged as a prominent player in the medical field, witnessing a remarkable surge from $14 to $90 in a little over 18 months. The company's core expertise lies in organ care systems, which preserve transplant organs post-donor retrieval. It further distinguishes itself by offering comprehensive clinical-level support to transplant centers and is a full-service provider for transplantation logistics. Read the full story here | | | | | |
- G. O'Fiachra We value your feedback: Please let us know what you think about our investing ideas so far, and any recommendations you may have for increasing the value of this newsletter. Please follow this link for a quick, 2-minute survey You Might Also Like:  |
|
| | Advertising Disclosure: This email may contain paid advertisements. Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world. We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com. Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here. If you can't see this message, view it in your browser. You are receiving this e-mail at stevenmagallanes520.nims@blogger.com as a part of your free subscription to the Spotlight Newsletter. To read our privacy policy follow this link. or To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311 Website: Summa Money Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright 2022 Summa Money. All rights reserved. |
|
|
In order to unsubscribe from this mailing list, please click
here 
No comments:
Post a Comment